跳至主要内容
临床试验/IRCT20230103057035N1
IRCT20230103057035N1招募中2 期

Evaluation of the effect of Interferon Alfa-2b in combination with intra-vitreal injection of Bevacizumab in the treatment of diabetic macular edema: a randomized double-blinded clinical trial

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 49 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
49

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 80 years(—)
性别
All

入选标准

  • Diabetic patients over 18 years old
  • Macular edema involving the center.
  • BCVA between 20/400-40/20
  • Central macular thickness greater than or equal to 300 µm
  • Requires 3 IVB injections in the next 12 weeks
  • Retinal clarity, pupillary dilation for OCT, and necessary cooperation for proper fundus photography

排除标准

  • 未提供

研究者

相似试验